Publications

Export 82 results:
Sort by: Author [ Title (Desc)] Type Year
Filters: First Letter Of Title is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S [T] U V W X Y Z   [Show ALL]
T
Pawson AJ, Morgan K, Maudsley SR, Millar RP. Type II gonadotrophin-releasing hormone (GnRH-II) in reproductive biology. Reproduction. 2003;126(3):271-8. Abstract
Drake AJ, Smith A, Betts PR, Crowne EC, Shield JP. Type 2 diabetes in obese white children. Arch Dis Child. 2002;86(3):207-8. Abstract
Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579-89. Abstract
Corselli M, Chen C-, Sun B, Yap S, Rubin PJ, Péault B. The Tunica Adventitia of Human Arteries and Veins as a Source of Mesenchymal Stem Cells. Stem cells and development. 2011. Abstract
Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE, et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene. 1994;9(2):603-9. Abstract
Friedrichsen S, Harper CV, Semprini S, Wilding M, Adamson AD, Spiller DG, et al. Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling. Endocrinology. 2006;147:773-81. Abstract
Barat P, Gayard-Cros M, Andrew R, Corcuff J-, Jouret B, Barthe N, et al. Truncal distribution of fat mass, metabolic profile and hypothalamic-pituitary adrenal axis activity in prepubertal obese children. J Pediatr. 2007;150(5):535-9, 539.e1. Abstract
El Meziane A, Lehtinen SK, Hance N, Nijtmans LG, Dunbar D, Holt IJ, et al. A tRNA suppressor mutation in human mitochondria. Nat Genet. 1998;18(4):350-3. Abstract
Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. European heart journal. 2008;29:609-17. Abstract
Blackhurst G, Strachan MW, Collie D, Gregor A, Statham PF, Seckl JE. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clinical endocrinology. 2002;57:401-4. Abstract
Brouard N, Chapel A, Neildez-Nguyen TM, Granotier C, Khazaal I, Péault B, et al. Transplantation of stromal cells transduced with the human IL3 gene to stimulate hematopoiesis in human fetal bone grafts in non-obese, diabetic-severe combined immunodeficiency mice. Leukemia. 1998;12(7):1128-35. Abstract
Brouard N, Chapel A, Thierry D, Charbord P, Péault B. Transplantation of gene-modified human bone marrow stromal cells into mouse-human bone chimeras. J Hematother Stem Cell Res. 2000;9(2):175-81. Abstract
Drake AJ, Seckl JR. Transmission of programming effects across generations. Pediatr Endocrinol Rev. 2011;9(2):566-78. Abstract
Newby DE, Webb DJ. Translational research: a priority for health and wealth. Heart. 2010;96(11):815-6.
Newbery HJ, Loh DH, O’Donoghue JE, Tomlinson VA, Chau Y-, Boyd JA, et al. Translation elongation factor eEF1A2 is essential for post-weaning survival in mice. The Journal of biological chemistry. 2007;282:28951-9. Abstract
Chang S-, Mullins JJ, Morley SD, West JD. Transition from organogenesis to stem cell maintenance in the mouse adrenal cortex. Organogenesis. 2011;7(4). Abstract
Heijnen BF, Peutz-Kootstra CJ, Mullins JJ, Janssen BJ, Struijker-Boudier HA. Transient renin-angiotensin system stimulation in an early stage of life causes sustained hypertension in rats. J Hypertens. 2011;29(12):2369-80. Abstract
Jamieson PM, Chandler ML. Transient renal tubulopathy in a Labrador retriever. J Small Anim Pract. 2001;42(11):546-9. Abstract
Howard CG, Mullins JJ, Mitchell KD. Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats. The American journal of the medical sciences. 2010;339:543-8. Abstract
Mullins LJ, Morley SD, Mullins JJ. Transgenics and essential hypertension. Journal of human hypertension. 1996;10:627-31. Abstract
Ganten D, Lindpaintner K, Ganten U, Peters J, Zimmermann F, Bader M, et al. Transgenic rats: new animal models in hypertension research. Invited lecture. Hypertension. 1991;17(6 Pt 2):843-55.
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science (New York, N.Y.). 2001;294:2166-70. Abstract
Mullins L, Mullins J. Transgenic approaches to modification of cell and tissue function. Current opinion in cell biology. 1991;3:192-8. Abstract
Kalló I, Kalamatianos T, Wiltshire N, Shen S, Sheward JW, Harmar AJ, et al. Transgenic approach reveals expression of the VPAC2 receptor in phenotypically defined neurons in the mouse suprachiasmatic nucleus and in its efferent target sites. The European journal of neuroscience. 2004;19:2201-11. Abstract
Mullins JJ, Ganten D. Transgenic animals: new approaches to hypertension research. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 1990;8:S35-7. Abstract